METAFIT HEALTH TECHNOLOGIES PRIVATE LIMITED

What METAFIT HEALTH TECHNOLOGIES PRIVATE LIMITED does

MetaFit Health Technologies Private Limited operates an India-focused telehealth platform that delivers doctor-led GLP-1 weight-loss programs to adults with obesity or overweight. The platform combines prescription access to semaglutide and tirzepatide (Mounjaro) with a unified Flutter-based mobile app available on iOS, Android, and web. The app integrates AI-powered food photo logging (Snap & Track), a 24/7 generative-AI coaching chatbot (Fit AI), GLP-1 dose tracking, wearable device sync, live workouts, and gamified journey mapping with XP rewards. Care is delivered by a 30+ doctor clinical team and the company maintains a 4.8-star service rating across 5,300+ members.

The business is structured around three tiered subscriptions sold direct-to-consumer: MetaFitSure (₹5,999/month, the flagship plan with full doctor-led care, medications, and AI support), MetaFitPro (nutrition plus trainer support), and MetaFit+ (AI coaching base tier). Go-to-market is a hybrid model combining a free eligibility check as a product-led-growth entry point with consultative conversion to paid tiers, supported by an SEO-driven content library, a referral program, and doctor-led credibility marketing. Quest Diagnostics is integrated into the clinical workflow for lab testing. No external funding rounds are disclosed, suggesting bootstrapped or near-bootstrap operations.

Strategically, the company is positioning for the 115% growth in India's anti-obesity market in 2025 and the March 2026 Indian patent expiry of semaglutide, which enables a generic GLP-1 product line that materially lowers input cost and broadens the addressable patient pool. The integrated stack of prescription authority, AI coaching, lab integrations, and content-driven acquisition forms the basis of MetaFit's competitive position in a category that is otherwise fragmented across standalone diet apps, local endocrinologists, and offline clinics.

Name

METAFIT HEALTH TECHNOLOGIES PRIVATE LIMITED

Legal name

Metafit Health Technologies Private Limited

Website

https://joinmeta.fit

Company type

Private

Founded year

2026

Operating status

Operating

Short description

MetaFit Health Technologies Private Limited is an India-focused telehealth platform that combines doctor-prescribed GLP-1 weight-loss therapy (semaglutide, tirzepatide) with an AI-powered mobile app for food logging, coaching, and dose tracking, serving 5,300+ Indian adults with obesity through tiered subscriptions.

Ownership category

akta.pro rank

Product category

Telehealth

NAICS

Diet and Weight Reducing Centers (812191)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Obesity Medicine & Weight Management (HLAKADAL)

akta.pro secondary industries

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Weight Loss Coaching (Non-Clinical) (HSADAFAB), Weight Management & Behavior Change Education (EDAAAHAF)

Keywords

• Weight loss programs
• Telehealth services
• GLP-1 medication therapy
• AI fitness coaching
• Metabolic health tracking

Headquarters

HQ city

Noida

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Subscription Plans (MetaFit+, MetaFitPro, MetaFitSure): MetaFit generates revenue primarily through tiered subscription plans. The MetaFitSure program is priced at ₹5,999/month and includes doctor consultation, AI-guided tracking app, at-home diagnostics, doorstep medication delivery where prescribed, and an ongoing dedicated care team. Plans auto-renew monthly or annually depending on the tier selected. Cancellation stops future auto-debit; access continues through the end of the paid billing period.
2. Platform Transaction Fees (via Payment Gateways): Payments are processed via Apple App Store (iOS), Google Play Store (Android), and Razorpay/PhonePe/Stripe (website). MetaFit records subscription plan type, purchase date, renewal date, and transaction IDs from these processors. The company does not charge separate transaction fees from customers — the payment gateway costs are absorbed within the subscription price.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Core offering

MetaFit runs a fully online, doctor-led GLP-1 weight loss program in India, prescribing semaglutide and tirzepatide after a clinical consultation and delivering medications to the customer's doorstep. The MetaFitSure flagship program (₹5,999/month) combines the prescription service with an all-in-one AI-powered mobile app that handles food photo logging, 24/7 AI coaching, gamified progress tracking, live workouts, wearable integration and GLP-1 dose reminders. A multi-disciplinary care team of 30+ doctors and certified nutritionists delivers 1:1 physician guidance, ongoing check-ins, personalised Indian-diet nutrition plans and resistance-training guidance for muscle preservation.

Product overview

MetaFit is a comprehensive telehealth platform for doctor-led GLP-1 weight loss in India, combining prescription medications with an all-in-one digital ecosystem. The product portfolio includes two subscription tiers — MetaFit+ (AI coaching and health monitoring) and MetaFitPro (adds nutrition and trainer support) — plus the flagship MetaFitSure program (adds doctor consultations). Core features delivered through the MetaFit app include AI-powered food photo logging (Snap & Track), a 24/7 Fit AI chatbot, gamified weight loss journey mapping, live trainer workouts, GLP-1 dose reminders, and access to a dedicated care team. The platform facilitates prescriptions for GLP-1 medications (semaglutide and tirzepatide) after clinical review, with medications and at-home diagnostics delivered directly to users.

Differentiator

Problem solved

Functional benefit

Products and services

• MetaFitSure Flagship comprehensive weight-loss program priced at ₹5,999/month that combines doctor-prescribed GLP-1 medication (semaglutide or tirzepatide) with doorstep delivery, an all-in-one AI coaching and tracking app, at-home diagnostics, and a dedicated care team (doctor, nutritionist, coach) with ongoing 1:1 check-ins. Includes a weight-loss guarantee and 100% online pan-India access; designed for Indian adults with obesity or BMI 27+ with weight-related metabolic conditions.
• MetaFit Mobile App All-in-one cross-platform mobile and web application (Flutter-based, package ID fit.joinmeta.metafit_flutter_app) serving as the central digital platform for MetaFit's weight-loss ecosystem. Available on iOS App Store and Google Play, providing AI-powered food photo logging (Snap & Track), the Fit AI chatbot, gamified journey tracking, live workouts, wearable sync and GLP-1 dose reminders.
• GLP-1 Medication Program Doctor-prescribed GLP-1 medication service covering semaglutide (including generics post-March 2026 patent expiry) and tirzepatide (Mounjaro, available in India from March 2025). Medications are dispensed only after a qualified online medical consultation and delivered to the customer's doorstep via licensed pharmacy partners in compliance with DCGI/CDSCO regulations.
• Free Eligibility Check Complimentary online health review in which a qualified clinician evaluates the prospective member's BMI, weight-related conditions, medical history and goals to determine eligibility for GLP-1 medication and the MetaFit program. No commitment is required to receive the eligibility determination; serves as the primary top-of-funnel demand-generation tool.

Quantifiable outcome

• Average ~20% body weight reduction in the first 12 months on the MetaFit program (individual results vary)
• +4 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability7 records

Feature7 records

Partnerships

Seven partnerships are on record, tiered supporting and core.

• Quest Diagnostics (implied lab partner — referenced as 'Quest' in FAQ page)supportingTechnology or IntegrationMetaFit's FAQ page references that members receive 'access to a metabolic lab test at Quest', indicating a partnership or integration with Quest Diagnostics for at-home lab testing services. Quest provides the diagnostic infrastructure for metabolic lab panels ordered through the MetaFit platform.
• Licensed Pharmacies (pharmacy partners)coreOthersMetaFit sources GLP-1 medications (semaglutide, tirzepatide) from licensed pharmacy partners for doorstep delivery to customers. All medications are dispensed from licensed pharmacies in compliance with DCGI and CDSCO regulations. The company states it does not sell medications directly but facilitates prescriptions through these partners.
• Apple App StorecoreChannel Partner/ Reseller/ DistributorApple processes all iOS app subscription payments and manages billing, renewals, and refunds for iOS users. MetaFit iOS subscribers are billed through their Apple ID. This is a core distribution and payments partnership for the iOS customer segment.
• Google Play StorecoreChannel Partner/ Reseller/ DistributorGoogle processes all Android app subscription payments and manages billing, renewals, and refunds for Android users. MetaFit Android subscribers are billed through their Google Account. This is a core distribution and payments partnership for the Android customer segment.
• Razorpay / PhonePecoreTechnology or IntegrationRazorpay and PhonePe handle payment processing for website transactions including UPI, debit/credit cards, and wallets. Payments are subject to RBI e-mandate guidelines, including 24-hour pre-debit notifications and 2FA/OTP authentication for the first transaction.
• StripesupportingTechnology or IntegrationStripe processes international card payments on the MetaFit website for customers using non-Indian payment methods. Along with Razorpay and PhonePe, Stripe is part of MetaFit's website payment processing infrastructure.
• AWS / GCP (cloud infrastructure)supportingTechnology or IntegrationMetaFit's Privacy Policy references cloud hosting through AWS or GCP as a service provider, with data processing agreements in place. These cloud platforms support the company's application infrastructure, data storage, and platform security.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Mfine: India-based telehealth platform offering online specialist consultations, including endocrinology and weight management, with subscription and per-consultation pricing. Directly comparable on the doctor-led telehealth model serving Indian consumers for chronic/metabolic conditions.
• HealthifyMe: India's largest AI-powered nutrition and weight-loss platform with subscription plans, AI coach 'Ria', and a strong India-specific food database. Most directly comparable to MetaFit on target customer, business model, and category; differs in that HealthifyMe is not primarily a GLP-1 prescription clinic.
• Zyla Health: India-based chronic-disease management platform offering personalized care programs for diabetes, hypertension, and cardiac conditions with a human care team and digital tools. Directly comparable on the India-focused chronic-care telehealth model with multidisciplinary care teams.
• Cult.fit: Indian fitness and weight-loss subscription brand combining online coaching, live trainer sessions, and nutrition plans. Comparable on consumer weight-loss subscription model and India-focused GTM, though Cult.fit's core offering is fitness-led rather than medically-led GLP-1 care.
• Found (Found Health): US-based telehealth platform offering doctor-prescribed weight-loss care including GLP-1 medications paired with behavior-change coaching. Closely comparable on care model and subscription pricing logic, though operating only in the US and not India.

Emerging players

• Noom: Globally scaled weight-loss app that has expanded into GLP-1 telehealth via Noom Med. Comparable on subscription coaching + weight-loss content model; differs in that Noom is behavior-change-led rather than India-metabolic-phenotype-led.

Broad incumbents

• Ro: US telehealth platform offering direct-to-consumer prescription weight loss including GLP-1s through its 'Ro Body' program, with integrated app, coaching, and at-home lab testing. Highly comparable on the care-bundle structure; operates only in the US and at significantly larger scale.
• Tata 1mg: One of India's largest online pharmacy and digital health platforms owned by Tata Digital, offering e-pharmacy, lab tests, and teleconsultations including weight management. Comparable on integrated pharmacy + diagnostics + consultation stack; broader in scope and much larger in scale than MetaFit.
• Hims & Hers Health: US-listed direct-to-consumer telehealth platform that bundles prescription weight-loss care (GLP-1s) with a digital app and ongoing clinician support. Closest Western analog to MetaFit's bundle of prescription + app + care team, though operating at vastly larger scale and a different regulatory regime.

Regional players

• Pristyn Care: India-based digital health platform offering online consultations, in-home diagnostics, and ongoing care for chronic and lifestyle conditions. Comparable on India telehealth + home diagnostics + care-team model; less directly focused on GLP-1 weight loss but overlapping in chronic-metabolic customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about METAFIT HEALTH TECHNOLOGIES PRIVATE LIMITED